Form 4: CareDx Director Sells Shares

CareDx Director Arthur A. Torres reported transactions involving the sale of company common stock.

Summary

• Arthur A. Torres, a Director at CareDx, Inc., reported the sale of common stock on May 14, 2026, and May 15, 2026.
• On May 14, 2026, 4,086 shares were sold at a weighted average price of $20.9735, with individual sales ranging from $20.96 to $21.03.
• On May 15, 2026, 6,484 shares were sold at a weighted average price of $19.8917, with individual sales ranging from $19.73 to $20.105.
• Following these transactions, Mr. Torres beneficially owns 38,665 shares of common stock directly.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as slightly negative due to the director's sale of a notable number of shares, which can be interpreted as a bearish signal, despite the lack of explicit negative commentary.

Negatives

• Director Arthur A. Torres sold a significant number of shares (4,086 on May 14 and 6,484 on May 15) which could be perceived negatively by the market.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider selling, particularly by directors, can sometimes signal a lack of confidence in future stock performance, although it can also be for personal financial planning reasons.

Stakeholder Impact

• Shareholders may view the director's stock sales with concern, potentially impacting investor sentiment and share price.

Key Dates

Recommendation

The filing reports insider selling by a director, which warrants attention. However, without further context on the reasons for the sale or the company's overall performance, a 'hold' recommendation is prudent, suggesting investors monitor the situation rather than making immediate decisions.

Keywords

Form 4, SEC Filing, Insider Trading, Stock Sale, CareDx, CDNA, Director Transaction, Beneficial Ownership